Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00150800
Status:
COMPLETED
Last Update Posted:
2021-08-17
First Post:
2005-09-06
Brief Title:
This Trial Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy Who May Have Benefited From Brivaracetam as Adjunctive Treatment the Opportunity to Receive Open Label Brivaracetam Treatment
Sponsor:
UCB PHARMA Inc US
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
None
Primary Completion Date:
2017-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-06
First Submit QC Date:
September 6 2005
Study First Post Date:
2005-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-12-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-16
Last Update Post Date:
2021-08-17
Last Update Post Date Type:
ACTUAL